SoundThinking Q2 revenue misses estimates, trims 2026 outlook
SSTI•Analyst coverage
- The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
- The average consensus recommendation for the software peer group is "buy"
- Wall Street's median 12-month price target for SoundThinking Inc is $12.00, about 47.2% above its August 12 closing price of $8.15
Outlook lowered for FY 2026
- SoundThinking lowers FY 2026 revenue guidance to $99.0 mln-$100.0 mln from $109.0 mln-$111.0 mln
- Company lowers FY 2026 adj EBITDA margin guidance to 8%-9% from 16%-18%
- SoundThinking expects ARR to exceed $100.0 mln at start of 2027, below prior $110.0 mln forecast
Related News
Chemours CEO Denise Dignam acquires 3,378 common shares for $50,501.1
CC•
U.S. FDA Grants Accelerated Approval To Bristol Myers Squibb's First Celmod Therapy Zenbexus™, In Combination With Daratumumab And Hyaluronidase-Fihj And Dexamethasone (Zdd) For Patients With Multiple Myeloma, As Early As First Relapse
BMY•
